ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Dakota » Internal Medicine

Top Internal Medicine Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JONATHAN OLEGARIO M.D.

Internal Medicine

19,004

$1.3M

628
501 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $51

ROBERT NEUMAYR MD

Internal Medicine

18,943

$875K

702
613 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $51

DANIEL MEGARD MD

Internal Medicine

17,010

$757K

885
794 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $51

DANIEL CECIL MD

Internal Medicine

16,327

$953K

607
539 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $51

GARY BUBAK MD

Internal Medicine

16,324

$636K

390
347 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 23%

$39
Average prescription price

Avg: $51

SYED SHAH MD

Internal Medicine

16,323

$657K

516
446 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$40
Average prescription price

Avg: $51

WILLIAM MINER M.D.

Internal Medicine

16,146

$718K

477
415 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $51

LUCIO MARGALLO MD

Internal Medicine

15,956

$989K

612
530 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 23%

$62
Average prescription price

Avg: $51

DAVID NELSON M.D.

Internal Medicine

15,033

$702K

644
597 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $51

TRAVIS HENDERSON MD

Internal Medicine

14,443

$669K

364
327 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$46
Average prescription price

Avg: $51

CANDACE ZEIGLER M.D.

Internal Medicine

14,281

$604K

500
472 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $51

ERIC LARSON M.D.

Internal Medicine

14,206

$644K

551
500 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $51

TIMOTHY WATERMAN MD

Internal Medicine

13,971

$488K

420
383 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $51

MICHAEL TOBIN M.D.

Internal Medicine

13,775

$756K

512
459 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$55
Average prescription price

Avg: $51

SUSAN FANTA MD

Internal Medicine

13,722

$713K

685
593 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$52
Average prescription price

Avg: $51

PHILLIP HOFFSTEN M. D.

Internal Medicine

13,676

$908K

435
388 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

15%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $51

CALVIN ROSETH MD

Internal Medicine

13,642

$613K

498
432 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$45
Average prescription price

Avg: $51

SCOTT PURINTUN MD

Internal Medicine

13,587

$568K

489
435 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$42
Average prescription price

Avg: $51

JEREL TIESZEN M.D.

Internal Medicine

13,528

$666K

591
563 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $51

GREGORY WIEDEL M.D.

Internal Medicine

13,368

$901K

401
309 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$67
Average prescription price

Avg: $51

RICHARD NELSON M.D.

Internal Medicine

13,135

$667K

593
547 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $51

DAVID MALTERS MD

Internal Medicine

13,068

$568K

523
462 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $51

DOUGLAS TRAUB

Internal Medicine

12,794

$864K

506
441 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $51

ELOISE SCHRAG MD

Internal Medicine

12,785

$558K

369
342 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $51

PATRICIA MALTERS MD

Internal Medicine

12,564

$620K

558
482 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$49
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank